Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Triple Negative Breast Neoplasms

NCT01818063 2025-04-30

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2 Completed

9 enrolled 10 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02423603 2025-03-10

PAKT

Phase 2 Completed

71 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03715959 2025-02-25

Nipple Aspirate Fluid in Detecting Breast Cancer

Phase NA Completed

2 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT06618014 2025-01-16

NeoTOP

Phase 2 Completed

51 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03981705 2024-12-27

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Completed

8 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03206203 2024-12-12

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Phase 2 Completed

106 enrolled 15 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02266420 2024-12-03

COCABIO000

Phase NA Completed

151 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03487666 2024-12-03

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

Phase 2 Completed

45 enrolled 15 charts

Breast

Triple Negative Breast Neoplasms

NCT04111510 2024-11-21

Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer

Phase 2 Completed

6 enrolled 13 charts

Breast

Triple Negative Breast Neoplasms

NCT03356860 2024-11-20

B-IMMUNE

Phase 1/2 Completed

57 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02938442 2024-11-07

Vaccination of Triple Negative Breast Cancer Patients

Phase 1/2 Completed

16 enrolled 30 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03004183 2024-10-15

STOMP

Phase 2 Completed

57 enrolled 12 charts

BreastThoracic

Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT03164993 2024-10-15

ALICE

Phase 2 Completed

68 enrolled

Breast

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

NCT03207529 2024-10-10

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Phase 1 Completed

18 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02689427 2024-09-19

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Phase 2 Completed

24 enrolled 7 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05111067 2024-08-21

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

Completed

120 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04464174 2024-07-26

PATHFINDER

Phase 2 Completed

54 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04408118 2024-06-04

ATRACTIB

Phase 2 Completed

100 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02996825 2024-04-02

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

Phase 1 Completed

44 enrolled

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

TORCHLIGHT

NeoSACT

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

RADIOLA

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

OPALESCENCE

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

A-Brave

A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

PRIMED

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

RadioPARP

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

ROLo

Axillary Nodal Burden in HER2+ and TNBC

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

TIL; PD1; PDL1

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

PAKT

Nipple Aspirate Fluid in Detecting Breast Cancer

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NeoTOP

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

COCABIO000

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer

B-IMMUNE

Vaccination of Triple Negative Breast Cancer Patients

STOMP

ALICE

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

PATHFINDER

ATRACTIB

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer